Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Final Provider-Administered Drug Precertification Policies .

ph-0105

Elelyso

ph-0109

Rituxan, Truxima, Ruxience, Riabni

ph-0114

Soliris, Bkemv, Epysqli

ph-0117

Stelara, Wezlana, Selarsdi, Pyzchiva, Otulfi. Imuldosa, Yesintek, Steqeyma, Ustekinumab-aekn, Ustekinumab-ttwe§; Ustekinumab-aauz§; Ustekinumab-stba§; Ustekinumab§

Synagis

Tysabri, Tyruko

Vivitrol

VPRIV

Xiaflex

Xolair

Krystexxa

Kalbitor

Cinryze

Firazyr

Simponi ARIA

Ilaris

Visudyne

Vimzim

Entyvio

Ruconest

Category Filter

Asset Publisher

Content with Policies & Guidelines Final Provider-Administered Drug Precertification Policies .